Lucanix: A Vaccine Being Tested as a "Maintenance" Strategy in Advanced NSCLC

Article

Over the past several weeks, coincident with the opening of a new large clinical trial and some publicity associated with that, several people have asked me here about a lung cancer vaccine called Lucanix (full name belagenpumatucel-L, so a near guarantee that nobody will call this anything but Lucanix). My initial response was that I knew essentially nothing about it and more or less implied that there must not be much to it if there was really no buzz about it within the lung cancer community.

Subscribe to lucanix